MACROGEN

Macrogen, K-Quarantine System “Smart Mobile Lab”

- First-ever prefab on-site testing system for COVID-19 in Korea - Supply of all-in-one comprehensive mobile container-type COVID-19 testing system - Securing a bridgehead for global export by supplyi

2020.09.28

Macrogen Obtains Europe's CE-IVD Certificate for its COVID-19 Test Kit

- Export of test kit to entire Europe and numerous countries that recognize CE-IVD gains impetus The Korean biotech company Macrogen (CEO Sukang Lee), announced on the 3rd that it had obtained the CE

2020.08.04

Macrogen Approved for Export of its COVID-19 Test Kit

The Korean biotech company Macrogen (CEO Sukang Lee) (KOSDAQ: 038290), announced that it obtained export approval for COVID-19 test kit ‘AxenTM COVID-19 RT’ from the Ministry of Food and Drug Safety (

2020.05.20

[Press Release] Now, Get A Free Knock-out Mouse: The Improved Sperm-freezing Technology Enables Macrogen to Open the Overseas GEM Market

- Macrogen's improved technology helps to increase Mouse birth rate by 30% - Macrogen celebrates launching its first overseas GEM services by hosting free order event of CRISPR KO Mouse for the US, Eu

2020.03.03

[Press Release] Macrogen Signs License and Supply Agreement with Thermo Fisher Scientific

- License and Supply Agreement with Thermo Fisher Scientific signed at Macrogen headquarters - Further development of the global CES market expected by expanding Macrogen’s “Genome Supermarket” strate

2020.01.14

[Press Release] Psomagen-Macrogen Consortium Acquires All Patents and Data from US company uBiome

On January 2nd, the Psomagen-Macrogen Consortium announced the acquisition of all key assets of US company uBiome. Through the move, Psomagen has become a key p in the microbiome sector, a promising n

2020.01.03

[Press Release] Macrogen Research Outcome from ‘Genome Asia 100K’ Covered in Nature

- The largest number of regions and races included in any Asian reference panel - Identification of genome diversity within Asian ethnic groups and differences in drug response SEOUL, South Korea--The

2019.12.05

[Press release] Macrogen: Successful Construction of the Largest Northeast Asian Reference Panel

- Reference panel expected to contribute to discover the Northeast Asian specific illness-related genes, and to develop tailored diagnosis method - A second reference panel from 10,000 individuals wil

2019.12.04

[Press release] Psomagen and Macrogen Granted U.S. Patent for Blockchain Data-sharing Technology

- Patent granted for blockchain technology for data transaction brokerage and sharing between data providers and users - Allows individuals to have control over their healthcare data - Technology to b

2019.09.18

[Press release] Macrogen Announces Strategic Investment in Australian Microbiome Company, Microba

- Share subion agreement of 4.1million AUD with Microba - Microbiome data construction in Asia Pacific region within the year, followed by global service launch in early 2020 - Plans to preempt global

2019.06.13

[Press release] Macrogen Receives GCLP Accreditation

- Macrogen is the first and only NGS-d institute in Korea to receive GCLP accreditation - Increased demands from multinational pharmaceutical companies for NGS analysis for companion diagnostics and t

2019.05.29

[Press Release] Macrogen and Exosome Plus to Jointly Develop Exosome-based Diagnostic and Treatment Solutions

- Contract signed for Macrogen to become the exclusive buyer of ‘Exosome Plus’ high-efficiency exosome isolation kit, ‘Exo2D™’ - MOU signed for the joint development of exosome-d diagnostic and treatm

2019.04.24

[Press release] Macrogen Becomes the First Clinical Lab in Korea to Receive CLIA Accreditation

- NGS labs in Seoul headquarters and Bundang Precision Medicine Center become the first in Korea to receive CLIA accreditation - Only company in Korea with both CLIA and CAP-accredited NGS clinical la

2018.12.27

[Press release] Macrogen Receives CAP Accreditation in Two Clinical Laboratories in Korea

- NGS Clinical Laboratories in Seoul headquarters and Bundang Precision Medicine Center Simultaneously Received the CAP Accreditation - Expected to Expand the Clinical Diagnostics Market in Korea and

2018.08.13

[Press release] Macrogen Establishes Overseas Corporation in Singapore to Focus on Southeast Asian Market in Earnest

Macrogen Establishes Overseas Corporation in Singapore to Focus on Southeast Asian Market in Earnest - Macrogen establishes ‘Macrogen Asia Pacific’, a Subsidiary in Singapore - Targeting Southeast Asi

2018.06.05

[Press Release] Macrogen Licenses Gene Editing Technology from Broad Institute of MIT and Harvard in the USA

- CRISPR-Cas9 commercial research tool technology acquired from Broad Institute will be used to build preclinical model animals and target treatment function analysis to further gene treatment researc

2018.04.06

[Press Release] Macrogen Corp.'s Clinical NGS Laboratory Receives CAP Accreditation

ROCKVILLE, MD-- Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of

2018.04.03

[Press Release] Macrogen Established its Branch in Spain, Strengthening Localization Service in Europe

Macrogen Established its Branch in Spain, Strengthening Localization Service in Europe - Establishment of Genome Sequencing Industry’s First Branch in Spain, Strengthening Localization Service in Sout

2018.04.02

[Press Release] Macrogen Leads Precision Medicine by Advancing the Realization of the “$100 Genome Age”

- Completed the Installation of NovaSeq 6000, the Latest Genome Analysis Equipment by Illumina - Capacity for Genome Analysis Service Doubled and Capable of Analyzing More Than 70,000 People Per Year

2018.04.02